Nomura Holdings’s State Street SPDR S&P Biotech ETF XBI Stock Holding History

Nomura Holdings’s Portfolio XBI Stock Details XBI Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$12.1M	Buy	95,000 +5,100	+6%	+$637K	0.03%	377
2025 Q4	$11M	Sell	89,900 -27,600	-23%	-$3.16M	0.01%	494
2025 Q3	$11.8M	Sell	117,500 -570,000	-83%	-$51.3M	0.02%	475
2025 Q2	$57M	Buy	687,500 +535,000	+351%	+$42.7M	0.12%	108
2025 Q1	$12.4M	Sell	152,500 -122,500	-45%	-$10.9M	0.02%	421
2024 Q4	$24.8M	Sell	275,000 -800	-0.3%	-$77.5K	0.03%	268
2024 Q3	$27.2M	Buy	275,800 +3,300	+1%	+$324K	0.06%	200
2024 Q2	$25.3M	Sell	272,500 -25,000	-8%	-$2.24M	0.05%	221
2024 Q1	$28.2M	Sell	297,500 -89,500	-23%	-$8.3M	0.07%	195
2023 Q4	$34.6M	Buy	387,000 +79,500	+26%	+$5.9M	0.09%	169
2023 Q3	$22.5M	Buy	307,500 +147,500	+92%	+$11.8M	0.06%	204
2023 Q2	$13.3M	Buy	160,000 +80,000	+100%	+$6.69M	0.04%	277
2023 Q1	$6.1M	Buy	+80,000	New	+$6.64M	0.02%	493
2022 Q3	–	Sell	-250,000	Closed	-$19.1M	–	1989
2022 Q2	$19.1M	Buy	+250,000	New	+$18.8M	0.07%	184
2018 Q3	–	Sell	-1,000,000	Closed	-$95.2M	–	1542
2018 Q2	$95.2M	Buy	1,000,000 +900,000	+900%	+$82.7M	0.3%	54
2018 Q1	$8.81K	Buy	+100,000	New	+$9.13M	0.02%	430
2017 Q3	–	Sell	-200,000	Closed	-$15.3M	–	1639
2017 Q2	$15.3M	Buy	+200,000	New	+$14.2M	0.04%	250
2016 Q3	–	Sell	-125,000	Closed	-$6.73M	–	1409
2016 Q2	$6.73M	Buy	+125,000	New	+$6.85M	0.02%	362
2015 Q4	–	Sell	-25,000	Closed	-$1.94M	–	2122
2015 Q3	$1.94M	Buy	+25,000	New	+$1.97M	0.01%	601
2015 Q2	–	Sell	-52,500	Closed	-$3.89M	–	2068
2015 Q1	$3.89M	Buy	+52,500	New	+$3.67M	0.01%	442
2014 Q4	–	Sell	-75,000	Closed	-$3.91M	–	2778
2014 Q3	$3.91M	Buy	+75,000	New	+$3.82M	0.01%	793

Other funds holding XBI

BNP Paribas Financial Markets Paris, France $206B AUM 31.61% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Citigroup New York $235B AUM 32.99% 1-Year Est. Return

Healthcare of Ontario Pension Plan (HOOPP) Trust Fund Toronto, Ontario, Canada $62.2B AUM 31.35% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return

Barclays London, United Kingdom $416B AUM 33.63% 1-Year Est. Return

Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return

Nomura Holdings's XBI Position: Q3 2018 in Review

Nomura Holdings sold out of State Street SPDR S&P Biotech ETF (XBI) in Q3 2018, closing a stake of 3,532 shares — an estimated $336K sold.

Nomura Holdings first reported a position in XBI in Q2 2016 and held it in 5 quarters. The position peaked at $2.98M in Q2 2016. 432 funds tracked by Wall St. Rank hold XBI as of Q3 2018.

Nomura Holdings reported no remaining State Street SPDR S&P Biotech ETF position as of Q3 2018 after selling out during the quarter.
Nomura Holdings sold 3,532 State Street SPDR S&P Biotech ETF shares in Q3 2018, an estimated $336K.
Nomura Holdings first reported a position in State Street SPDR S&P Biotech ETF in Q2 2016 and held it in 5 quarters.
Nomura Holdings's State Street SPDR S&P Biotech ETF position peaked at $2.98M in Q2 2016.
432 funds tracked by Wall St. Rank held State Street SPDR S&P Biotech ETF as of Q3 2018.

Based on Nomura Holdings's 13F filing for Q3 2018, filed 14 Nov 2018.